The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
#270Alter Everything79.3 / 100Get badge
← The Index
Alter Everything artwork
AI & DataNEW this period

Alter Everything

Hosted by Alteryx

Welcome to Alter Everything - a podcast about AI, analytics, and the future of work. To view episode transcripts, leave comments, and

217 episodes · publishes fortnightly · latest 2026-06-10 · ~28 min/episode

Rank

#270

Substance

79.3

/ 100

Breakdown

Scored 2026-07
Updated monthly

AI & Data rank

#34 of 495

Best B2B AI & Data Podcasts →

Across the index

#270 of 6182

Substance

Top 4%

outscores 96% of the index

Why it scores where it does

Alter Everything ranks #270 on The B2B Podcast Index with a substance score of 79.3 out of 100, scored across 4 recent episodes. It scores highest on guest caliber and insight density. Dr. Ami Bhatt is exceptionally well-positioned: Chief Innovation Officer at American College of Cardiology, practicing cardiologist, FDA Digital Health Advisory Committee chair, advising government on healthcare AI infrastructure, and actively consulting with health tech companies on deployment. She operates at the intersection of clinical practice, policy, and innovation. This is a legitimately senior, relevant voice with real decision-making authority and ongoing operational exposure.

The five-dimension breakdown

Averaged across 4 recently scored episodes, with cited evidence.

Insight Density

16.5 / 20

The episode contains substantive frameworks and concrete examples - 'navigating to knowledge' vs. clinical decision support, the 'good enough' vs. perfect care trade-off in population health, collaborative intelligence, and specific use cases (EKG AI detecting liver disease, wearable monitoring). However, the conversation meanders with personal anecdotes (daughter's music/AI analogy, patient stories) that dilute density. There is valuable content but notable filler relative to what a busy operator needs.

“There is so much we know about...the human brain is just not able to take all of that and give you the best care possible. But it turns out we can give you the best care possible if we use the compute power”

“if you don't access any care, then when you eventually access care, you're gonna access care through an emergency department...if you take that as our baseline, anything that can help us get people to some version of care faster than they would have before”

Originality

14.8 / 20

The core framing of 'collaborative intelligence' vs. augmentation and the 'good enough' framework for population health are thoughtful contributions. The EKG aging detection research is interesting. However, much of the discussion relies on familiar healthcare AI tropes (administrative automation, clinical decision support concerns, physician burnout from documentation). The guest repackages existing concepts rather than presenting genuinely novel first-principles thinking.

“I like to call that navigating to knowledge, which is getting all the stuff we need, organizing it so that you and I can have a meaningful conversation”

“collaborative intelligence...the really good AI is gonna be the one where we collaborated in its design because we know this field”

Guest Caliber

18.0 / 20

Dr. Ami Bhatt is exceptionally well-positioned: Chief Innovation Officer at American College of Cardiology, practicing cardiologist, FDA Digital Health Advisory Committee chair, advising government on healthcare AI infrastructure, and actively consulting with health tech companies on deployment. She operates at the intersection of clinical practice, policy, and innovation. This is a legitimately senior, relevant voice with real decision-making authority and ongoing operational exposure.

“I spend most of my time either talking with companies, big and small, who are bringing promising technologies forward, especially in terms of how we deliver care, but are struggling with scale”

“I spend a good amount of time with the government formally with the FDA as the Digital Health Advisory Committee's chair, informally with the Center for Medicare and Medicaid Innovation, with the GAO”

Specificity & Evidence

15.0 / 20

The episode includes concrete examples: voice-to-text adoption reducing documentation burden, EKG detecting liver disease and stress-induced age acceleration, wearable companies monitoring cardiac risk from earpieces, specific mention of Piedmont Heart Institute, ultrasound-plus-AI identification of fetal disease in remote settings. However, most claims lack precise metrics - no adoption percentages, no specific financial impact data, no exact diagnostic accuracy numbers. The 'less than 50%' guideline adherence is cited but not sourced. Stories are illustrative but not quantified.

“Guideline directed medical therapy is kind of less than 50% for many diseases”

“There's a company that actually makes algorithms that can be fed into that so that just you wear it regularly during your day and it tells you if you're developing heart disease”

Conversational Craft

15.0 / 20

The host asks decent contextual questions and follows up on key themes (good enough vs. perfect, human replacement vs. augmentation), and the lightning round forces clarity. However, the host frequently validates or agrees rather than challenges. When Dr. Bhatt makes claims (e.g., 'AI will be part of practice whether they want it or not'), the host moves on rather than probing. There's little productive disagreement or sharp pushback on nuance - mostly affirming nods. The conversation is warm but lacks the edge that would test the guest's thinking.

“That's right. That's right. Absolutely.”

“That's magical, right?”

Standout episodes

  • 202: The State of AI in Healthcare and how to know when AI Is ‘Good Enough’

    2026-03-18

    89
  • 204: The Surprising Connection Between Data Foundations and AI's Value Ceiling

    2026-05-13

    83
  • 203: How to be Human in the Age of AI

    2026-04-15

    80

Rank over time

First period on the Index - history builds from here.

Episodes

4 scored on substance · 60 tracked in total.

  • 205: Get It to 80% - What AI Actually Changes for Marketing Teams

    2026-06-10 · 53 min

    65 / 100
  • 204: The Surprising Connection Between Data Foundations and AI's Value Ceiling

    2026-05-13 · 47 min

    83 / 100
  • 203: How to be Human in the Age of AI

    2026-04-15 · 49 min

    80 / 100
  • 202: The State of AI in Healthcare and how to know when AI Is ‘Good Enough’

    2026-03-18 · 46 min

    89 / 100

Frequently asked

What is Alter Everything's substance score?
Alter Everything scores 79.3 out of 100 for substance and ranks #270 on The B2B Podcast Index. That puts it ahead of 96% of the B2B podcasts we rank and #34 of 495 in AI & Data. The score reflects insight density, originality, guest caliber, specificity and conversational craft across recent episodes - not downloads.
Is Alter Everything worth listening to?
Yes - Alter Everything outscores 96% of the B2B ai & data podcasts and shows we rank on substance, so a ai & data operator is likely to come away with something useful.
Who hosts Alter Everything?
Alter Everything is hosted by Alteryx.
How often does Alter Everything publish?
Alter Everything publishes fortnightly, has 217 episodes, released its most recent episode on 2026-06-10.
Which Alter Everything episode should I start with?
Our highest-scoring recent episode is " 202: The State of AI in Healthcare and how to know when AI Is ‘Good Enough’" (89/100) - a good place to start.

Show off your #34 rank in AI & Data

Add this badge to your site - it links back here and updates automatically as you rank.

Ranked #34 on The B2B Podcast Index
Embed code
<a href="https://index.fame.so/show/alter-everything" target="_blank" rel="noopener">
  <img src="https://index.fame.so/badge/alter-everything/badge.svg" alt="Ranked #34 on The B2B Podcast Index" width="360" height="136" />
</a>
Markdown & other formats →

Track Alter Everything's rank

Get an email whenever this show moves up or down the Index. Monthly at most, no spam.

Listen / subscribe:WebsiteRSS

Guests who've appeared

Martin BroadhurstDr. Fern HalperTiankai FengDr. Amy Bhatt, MD

Topics this show covers

The themes that come up most across this show's episodes.

generative AI · 2Agentic AI · 2Data governance · 2AI governance · 2ChatGPTHubSpotClaude (Anthropic)Jasperinbound marketingPower AutomateCopilot ProMicrosoft ResearcherCopy.AIChange managementValue ceilingTDWI researchData foundationsUnstructured data repositories

More AI & Data podcasts

See all →
  • Possible

    Reid Hoffman

    97.0
  • Training Data

    Sequoia Capital

    95.0
  • No Hacks

    Slobodan "Sani" Manić

    91.2
  • No Priors

    Conviction

    89.0
  • The Data Exchange with Ben Lorica

    Ben Lorica

    88.0
  • The Genetics Podcast

    Sano Genetics

    87.0

Similar shows

Podcasts that dig into the same topics.

  • Bringing Data and AI to Life

    Informatica

    59.3
  • Evolving the Enterprise

    SnapLogic

    68.2
  • AI Security, Cyber Risk, and Cloud Strategy on ClearTech Loop

    ClearTech Research / Jo Peterson

    74.0
  • AI Pathfinder for Private Equity Podcast

    Steve Budd

    72.5
  • SaaS Scaled

    Qrvey

    70.5
  • RevOps FM

    Justin Norris

    82.8